Doctors say there have been a number of developments with new weight loss drugs, which could make them easier for patients to ...

Amgen's long-acting experimental obesity drug MariTide needs to be given at a low starting dose to limit side effects like vomiting, according to mid-stage trial results presented at a medical meeting ...

The fortune of the San Francisco-based telehealth company’s cofounder and chief executive, Andrew Dudum, crumbled by more ...

Amgen's late-stage weight-loss drug MariTide is getting ready to enter the final stages of testing as the company enrolls its ...

Amycretin, a new weight-loss treatment from Novo Nordisk, combines two hunger hormones, helping participants lose nearly ...

Amgen's experimental drug MariTide shows potential for significant weight loss in obese patients, despite notable side ...

The companies engaged in an increasingly heated war of words on Monday following the drugmaker's decision to end a collaboration.

Patients who took a GLP-1 drug fared better than those in a control group at keeping their blood glucose levels in a healthy ...

Discover how appetite suppressants like psyllium and glucomannan, as well as gut health boosters, can help curb cravings, balance blood sugar levels, and support long-term wellness.

A new drug called amycretin has shown it can help reduce body weight in two early-phase clinical trials. The drug, which ...

Mr. Funk was the managing editor of Pleroma Media, and worked as a breaking news reporter at The Messenger after spending 25 ...

Hims & Hers Health Inc.'s stock was headed for a record session of losses Monday after pharmaceutical giant Novo Nordisk, maker of the weight-loss drug Wegovy, said it was ending a collaboration with ...